Research Article

Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats

Figure 4

Correlations between the levels of fecal endotoxins and bacteria that do not produce endotoxins in F344 rats: (a) total Gram-positive bacteria, (b) phylum Actinobacteria, (c) genus Bifidobacterium, (d) species B. infantis, (e) other species of Bifidobacterium, (f) phylum Firmicutes, and (g) genus Lactobacillus. F344 rats were gavaged daily with APA microencapsulated B. infantis ATCC 15697 or saline during 38 days ( ). Correlations were performed at endpoint (day 38) using Pearson’s correlation in the saline and APA microencapsulated B. infantis ATCC 15697 treatment groups. Indicates statistical significance of the correlation ( ).
602832.fig.004a
(a) Total Gram-positive bacteria
602832.fig.004b
(b) Phylum Actinobacteria
602832.fig.004c
(c) Genus Bifidobacterium
602832.fig.004d
(d) Species B. infantis
602832.fig.004e
(e) Other species of Bifidobacterium
602832.fig.004f
(f) Phylum Firmicutes
602832.fig.004g
(g) Genus Lactobacillus